Drug Shortage Report for CODEINE CONTIN 50MG CONTROLLED RELEASE TAB
Report ID | 172772 |
Drug Identification Number | 02230302 |
Brand name | CODEINE CONTIN 50MG CONTROLLED RELEASE TAB |
Common or Proper name | Codeine Controlled Release Tablets |
Company Name | PURDUE PHARMA |
Market Status | MARKETED |
Active Ingredient(s) | CODEINE |
Strength(s) | 50MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 60 |
ATC code | R05DA |
ATC description | COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-10-27 |
Actual start date | 2022-10-27 |
Estimated end date | 2023-01-13 |
Actual end date | 2023-01-11 |
Shortage status | Resolved |
Updated date | 2023-01-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2022-10-27 | French | Compare |
v1 | 2022-10-27 | English | Compare |